Fortis Escorts told to deposit Rs 503 crore to DGHS within a month
Advertisement
NEW DELHI: Fortis Healthcare today said its subsidiary Escort Heart Institute & Research Center has been directed to deposit Rs 503.36 crore to Director General of Health Services within a month on account of unwarranted profit.
Fortis said Escort Heart Institute & Research Center (EHIRCL) had received an order dated June 9, 2016, from Directorate General of Health Services (DGHS) for the recovery of Rs 503.36 crore on account of unwarranted profit allegedly made by it by not complying with the conditions of allotment letter/lease deed.
"A writ petition was filed by EHIRCL before Hon'able High Court of Delhi challenging the order...subsequently Delhi High Court set aside the demand of Rs 503.36 crore and the matter was remanded to the Special Committee for hearing," Fortis said in a regulatory filing.
It further said "EHIRCL has informed that the Office of the Special Committee vied order dated May 28, 2018, has directed it to deposit an amount of Rs 503.36 crore in the account of the Delhi Government in favor of Director General of Health Services within a month of receiving this order".
Fortis said EHIRCL is in the process of evaluating available legal recourse as may be advised in this regard.
At present, Fortis is in the process of inducting new investor to the company. There were five suitors in the race for Fortis Healthcare out of which only four made binding bids.
Besides Munjals-Burmans, Manipal -TPG and IHH Healthcare, KKR-backed Radiant Life Care had also put in bidding offer.
China's Fosun Healthcare but did not make a binding bid for the Fortis.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.